This is not medical advice. This article explains what the FMCSA standard and the Medical Examiner's Handbook guidance say about insulin-treated diabetes. Whether any individual driver is medically qualified is determined by the driver's treating clinician and a certified medical examiner on the FMCSA National Registry — never by a software platform.
In This Guide
What the 2018 Rule Changed
For decades, insulin use was a near-automatic barrier to interstate commercial driving. A driver who needed insulin had to apply to the FMCSA for an individual exemption — a slow, federal, case-by-case process. That changed with the diabetes final rule published September 19, 2018, which became effective November 19, 2018. The rule created a new physical-qualification standard at 49 CFR 391.46 and moved the decision out of Washington and into the exam room.
Under the current framework, a driver with insulin-treated diabetes mellitus (ITDM) who maintains a stable insulin regimen and proper control of the disease can be physically qualified by a certified medical examiner during a routine DOT physical, provided the driver otherwise meets the standards in 49 CFR 391.41. The federal exemption program for diabetes was effectively replaced for most drivers by this examiner-level process. The key actor is no longer the agency — it is the driver's own treating clinician, working through a specific form.
The 391.46 ITDM Standard
Section 391.46 sets out a two-part evaluation. First, the driver's treating clinician — the licensed healthcare professional who manages and prescribes the driver's insulin — must evaluate the driver and confirm two things: a stable insulin regimen and proper control of the diabetes. Second, a certified medical examiner must perform the medical examination required under 49 CFR 391.43 and certify that the driver is qualified and "free of complications from diabetes mellitus that might impair" the ability to operate a commercial motor vehicle safely.
This split matters. The examiner is not second-guessing the driver's insulin management — that is the treating clinician's domain, attested on the form. The examiner is confirming the driver meets the overall federal standard and is not showing diabetes complications (for example, vision or circulatory issues) that would interfere with safe driving. Both pieces must be present for the driver to be certified under this section.
The two required evaluations under 49 CFR 391.46
Step 1 - Treating Clinician
Evaluates the driver and completes the MCSA-5870, attesting to a stable insulin regimen and proper control of the diabetes (49 CFR 391.46(b)).
Step 2 - Certified Medical Examiner
Performs the 49 CFR 391.43 exam and certifies the driver if qualified and free of diabetes complications that would impair safe operation (49 CFR 391.46(c)).
The MCSA-5870 and the 45-Day Window
The Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-5870, is the document that carries the treating clinician's attestation to the certified medical examiner. The treating clinician completes, signs, and dates the form and provides their full name, office address, and telephone number. The driver then presents the completed form to the examiner.
There is a firm timing rule attached to the form. Under 49 CFR 391.46, the medical examiner's examination must occur no later than 45 days after the treating clinician signed and dated the MCSA-5870. A form older than 45 days is stale — the driver would need a fresh assessment. This 45-day window is a hard regulatory deadline, not examiner discretion, and it is one of the most common reasons an ITDM driver has to repeat a step: the clinician form and the exam fall out of sync.
Hard rule, not guidance: the 45-day window
The 45-day limit between the treating clinician signing the MCSA-5870 and the medical examiner's exam is written into 49 CFR 391.46 — it is a regulatory deadline. Sequence the clinician visit and the DOT physical so the form does not expire in between. Tracking both dates is exactly the kind of expiration problem a records system is built to flag.
Certification Length and Renewal
When a certified medical examiner qualifies an ITDM driver, the certification period is capped at a maximum of 12 months. That ceiling is set by the certification rules in 49 CFR 391.45 as applied to ITDM drivers under 391.46(c). In practice, this means an insulin-treated driver is recertified at least once a year — more often than the 24-month cycle a fully unremarkable driver might receive.
Within that ceiling, the FMCSA's guidance to examiners (in the Medical Examiner's Handbook and advisory criteria) explains that an examiner may certify for a shorter period — for example, three months — when blood-glucose records are incomplete or the examiner wants closer monitoring before granting a longer card. That shorter interval is a guidance-driven examiner judgment, not a fixed number that applies to every diabetic driver. The 12-month ceiling is the regulatory bright line; what happens beneath it is examiner discretion informed by the records the driver brings.
Severe Hypoglycemia and Disqualification
The insulin standard includes a specific disqualifying event. Under 49 CFR 391.46(e), a driver who experiences a severe hypoglycemic episode is prohibited from operating a commercial motor vehicle. The rule defines a severe episode precisely: one that requires the assistance of another person, or that results in loss of consciousness, a seizure, or coma. A mild low that the driver self-treats is not, by itself, this disqualifying event.
The prohibition is not necessarily permanent. The driver may be reconsidered after the treating clinician determines that the cause of the episode has been addressed and completes a new MCSA-5870 form reflecting that. Again, the clinical judgment about whether the driver can return belongs to the treating clinician and the certified examiner. What a carrier owns is the recordkeeping: documenting the event, the do-not-drive status, and the updated clinician form before the driver is put back behind the wheel.
What counts as a "severe" hypoglycemic episode (49 CFR 391.46(e))
- An episode requiring the assistance of another person
- An episode resulting in loss of consciousness
- An episode resulting in a seizure
- An episode resulting in coma
Non-Insulin Diabetes
Section 391.46 applies only to insulin-treated diabetes. A driver whose diabetes is managed with diet, oral medication, or non-insulin injectables is evaluated under the general physical-qualification standard in 49 CFR 391.41, and does not need an MCSA-5870. That does not make diabetes irrelevant to the exam: the FMCSA's guidance to examiners notes that complications of poorly controlled diabetes — for example, advanced eye disease or nerve damage that could affect safe operation — can still bear on certification and on how long a card is issued.
The practical line for carriers is the treatment, not the diagnosis. The moment a driver starts insulin, the ITDM process and the MCSA-5870 apply, and the certification cycle typically tightens to the 12-month ceiling. A driver who moves from pills to insulin between physicals is a records event worth catching early.
The Records Side: What the Carrier Keeps
None of this is medical advice, and FileFlo is not a medical examiner — it does not certify drivers or evaluate anyone's diabetes. What a carrier is responsible for is the paper trail: the current Medical Examiner's Certificate, its expiration date, and the supporting documents the carrier keeps in the Driver Qualification File, including the MCSA-5870 where insulin is involved.
For an insulin-treated driver, the records burden is heavier than average precisely because the cycle is shorter. A 12-month (or three-month) card means the next exam comes around faster, and the treating-clinician form has to be refreshed and synced to the exam inside the 45-day window. FileFlo tracks the certificate and its expiration, stores the MCSA-5870 and certificate as records, and sends expiration alerts so the carrier can line up the next clinician visit and DOT physical before the current card lapses.
How FileFlo handles the ITDM paper trail
- Certificate tracking: Stores the Medical Examiner's Certificate and tracks its expiration date for every driver, including the tighter 12-month and 3-month cycles common for insulin-treated drivers.
- Supporting-document storage: Keeps the MCSA-5870 and the certificate organized in the driver's file so the carrier has the records it is required to retain — without certifying anyone or storing clinical judgments it has no business making.
- Expiration alerts: Flags the upcoming card expiration so the carrier can sequence the treating-clinician visit and the DOT physical inside the 45-day window before the current certificate lapses.
FileFlo is a compliance records platform, not a medical examiner. $89 or $299/month. 5-day free trial. No medical advice.
Key Takeaways
- The 2018 rule replaced the federal diabetes exemption for most drivers. Effective November 19, 2018, insulin-treated drivers are certified at the exam under 49 CFR 391.46 instead of applying to the agency.
- The treating clinician completes the MCSA-5870. It attests to a stable insulin regimen and proper control; the examiner then certifies if the driver is otherwise qualified.
- The 45-day window is a hard rule. The exam must happen within 45 days of the clinician signing the form — this is regulation, not examiner discretion.
- Certification is capped at 12 months. Shorter cards (e.g., 3 months for incomplete glucose records) are examiner-discretion guidance beneath that ceiling.
- A severe hypoglycemic episode disqualifies the driver under 391.46(e) until the treating clinician addresses the cause and completes a new MCSA-5870.
DOT Physical and Diabetes: FAQ
Common questions about the insulin standard, the MCSA-5870, and how an insulin-treated driver is certified. Educational summary of the FMCSA standard — not medical advice.
Yes. Since the FMCSA insulin rule took effect on November 19, 2018, a driver with insulin-treated diabetes mellitus (ITDM) can be certified through the standard exam under 49 CFR 391.46 instead of applying for a separate federal exemption. The treating clinician completes the Insulin-Treated Diabetes Mellitus Assessment Form (MCSA-5870) confirming a stable insulin regimen and adequate control, and the certified medical examiner certifies the driver if otherwise qualified. This describes the federal standard and is not medical advice about any individual driver.
The MCSA-5870 is the Insulin-Treated Diabetes Mellitus Assessment Form. Under 49 CFR 391.46(b), the treating clinician — the licensed healthcare professional who manages and prescribes the driver's insulin — completes, signs, and dates it, attesting that the driver maintains a stable insulin regimen and proper control of the diabetes. The driver must present the completed form to a certified medical examiner, and the examiner's exam must occur no later than 45 days after the treating clinician signed the form. The carrier keeps the form and the resulting Medical Examiner's Certificate as records.
Under 49 CFR 391.46(c) and the certification rules in 49 CFR 391.45, the certification period for a qualified ITDM driver is a maximum of 12 months — meaning the driver is recertified at least once a year. Guidance the FMCSA gives examiners notes that an examiner may certify for a shorter period (for example, three months) when blood-glucose records are incomplete or the examiner wants closer monitoring. The exact period is the examiner's determination within the regulatory ceiling, not a fixed number every driver receives.
Under 49 CFR 391.46(e), a driver who has a severe hypoglycemic episode — defined in the rule as one requiring the assistance of another person, or resulting in loss of consciousness, seizure, or coma — is prohibited from operating a commercial motor vehicle. The driver may be reconsidered after the treating clinician determines the cause has been addressed and completes a new MCSA-5870 form. This is the regulatory standard; any medical evaluation belongs to the treating clinician and the certified medical examiner, not to a records platform.
Diabetes managed with diet, oral medication, or non-insulin injectables is not covered by 49 CFR 391.46, which applies specifically to insulin-treated diabetes. Those drivers are evaluated under the general standard in 49 CFR 391.41. FMCSA guidance to examiners flags that uncontrolled diabetes with complications (such as advanced retinopathy or neuropathy affecting safe operation) can still affect certification length, and a driver who later starts insulin moves under the ITDM process. The MCSA-5870 is required only when insulin is part of the treatment.
FileFlo is a compliance records platform — not a medical examiner. It does not certify drivers or give medical advice. For an insulin-treated driver, FileFlo tracks the Medical Examiner's Certificate and its expiration date and stores the supporting documents the carrier must keep on file, such as the MCSA-5870 and the certificate itself. Because ITDM drivers are often on a 12-month (or shorter) cycle, FileFlo's expiration alerts help the carrier line up the next exam and the updated treating-clinician form before the current card lapses. Pricing is $89 or $299 per month with a 5-day trial.
Track Every Medical Card Before It Expires
FileFlo tracks each driver's Medical Examiner's Certificate, its expiration date, and the supporting documents your carrier keeps on file — including the MCSA-5870 for insulin-treated drivers. Get expiration alerts so the shorter ITDM renewal cycle never catches you off guard. FileFlo is a records platform, not a medical examiner: it gives no medical advice and certifies no one.
$89 or $299/month — No credit card required — 5-day free trial
Start with the DOT Physical Requirements Guide or the CDL Disqualifying Conditions overview.